جاهز للتشغيل
جاهز للتشغيل
U.S. health authorities have raised their response level to combat the Ebola epidemic in the Democratic Republic of Congo to Level 1, the highest, despite the fact that the risk to the United States remains low. They also confirmed that they have sent experimental treatments, including the drug "MBP134," to the country and neighboring Uganda to aid in fighting the outbreak, which has so far resulted in over 304 deaths and 1,115 cases. This step is part of their efforts to address the outbreak caused by a rare strain for which no approved vaccines or treatments are currently available.
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading